Replies to post #196247 on Biotech Values

[WorstLuck]

Not the same But similar. Until The new gen comes out This is going to be a huge drag On sales. The other question Regards The new generation And whether it will have any similar problems.

[dewophile]

ENTA
It could affect use in cirrhotics - that's more than a few patients. I think this could also jeaopardize the ESRX contract if enough pts and docs require/demand non-ABBV products
I think enta is more a play on abt-493 at this point

[ronpopeil]

Down 60%. Just bought shares

[jbog]

Enta back to IPO price. Wow